Literature DB >> 11349349

[Community diabetes educational intervention at the primary care level].

A G Aráuz1, G Sánchez, G Padilla, M Fernández, M Roselló, S Guzmán.   

Abstract

OBJECTIVE: To offer an educational alternative on diabetes, with the participation of patients with type 2 diabetes, their family members, and health care providers, adapted to local conditions and to these person's felt needs.
METHODS: Focused on the primary-care level, this program was carried out in the health area of El Guarco, which is in the province of Cartago, Costa Rica. The first stage of the project included a qualitative study of the knowledge and practices of both patients and health care providers, looking at diabetes prevention and control and the local availability of foods. Based on those results, an educational methodology was developed, educational manuals were written, and courses for health care providers, patients, and patients' families were implemented. Other strategies were developed to make the effort sustainable.
RESULTS: We found that patients did not associate family history or obesity with diabetes and that those persons were also confused about the symptoms of diabetes. Patients also received inconsistent nutrition messages from health care providers. Using the diabetes education manual as a base, the providers increased their knowledge of diabetes prevention, treatment, and education by an average of 85%. The diabetic patients who received educational training (mean age, 57.0 years, with a standard deviation of 8.9 years; 92% women) improved their glycemic control. Blood glucose levels decreased from 189 +/- 79 mg/dL (average and standard deviation) to 157 +/- 48 mg/dL (P < 0.05), and glycosylated hemoglobin (HbA1c) went from 11.3% +/- 2.4% to 9.7% +/- 2.3% (P = 0.05). There were no significant changes in body weight or lipid profile, except for triglycerides, which declined (P < 0.05).
CONCLUSIONS: This educational program was successfully incorporated into the regular activities of the El Guarco-area health centers. The primary-care level is ideal for carrying out educational programs for diabetes treatment and early detection that are directed at patients, their families, and health care providers.

Entities:  

Mesh:

Year:  2001        PMID: 11349349     DOI: 10.1590/s1020-49892001000300003

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  5 in total

1.  [Multi-professional diabetes education at the first level of health care].

Authors:  Ana Gladys Aráuz-Hernández; Sonia Guzmán-Padilla; Marlene Roselló-Araya; Gioconda Padilla-Vargas
Journal:  Aten Primaria       Date:  2006-05-31       Impact factor: 1.137

2.  The use of conversation maps in the metabolic control of diabetes in Brazilians: a randomized clinical trial.

Authors:  Vivian Saraiva Veras; Francisco Januário Farias Pereira Filho; Márcio Flávio Moura de Araújo; Carla Regina de Souza Teixeira; Maria Lúcia Zanetti
Journal:  J Diabetes Metab Disord       Date:  2019-01-26

Review 3.  Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus.

Authors:  E Vermeire; J Wens; P Van Royen; Y Biot; H Hearnshaw; A Lindenmeyer
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

4.  Developing and adapting a family-based diabetes program at the U.S.-Mexico border.

Authors:  Nicolette I Teufel-Shone; Rebecca Drummond; Ulrike Rawiel
Journal:  Prev Chronic Dis       Date:  2004-12-15       Impact factor: 2.830

5.  Effectiveness of a Multicomponent Intervention in Primary Care That Addresses Patients with Diabetes Mellitus with Two or More Unhealthy Habits, Such as Diet, Physical Activity or Smoking: Multicenter Randomized Cluster Trial (EIRA Study).

Authors:  Francisco Represas-Carrera; Sabela Couso-Viana; Fátima Méndez-López; Bárbara Masluk; Rosa Magallón-Botaya; Jose I Recio-Rodríguez; Haizea Pombo; Alfonso Leiva-Rus; Montserrat Gil-Girbau; Emma Motrico; Ruth Martí-Lluch; Francisco Gude; Ana Clavería
Journal:  Int J Environ Res Public Health       Date:  2021-05-28       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.